These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17210583)

  • 1. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia.
    López-Novoa JM
    Nephrol Dial Transplant; 2007 Mar; 22(3):712-4. PubMed ID: 17210583
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarker for hypertension-preeclampsia: are we close yet?
    Sibai BM
    Am J Obstet Gynecol; 2007 Jul; 197(1):1-2. PubMed ID: 17618741
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation.
    Sekizawa A; Purwosunu Y; Farina A; Shimizu H; Nakamura M; Wibowo N; Rizzo N; Okai T
    BJOG; 2010 Apr; 117(5):557-64. PubMed ID: 20121832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental origins of angiogenic dysfunction in mirror syndrome.
    Bixel K; Silasi M; Zelop CM; Lim KH; Zsengeller Z; Stillman IE; Rana S
    Hypertens Pregnancy; 2012; 31(2):211-7. PubMed ID: 22150085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining and predicting preeclampsia.
    Lindheimer MD; Umans JG
    N Engl J Med; 2006 Sep; 355(10):1056-8. PubMed ID: 16957153
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule.
    Luft FC
    Nephrol Dial Transplant; 2006 Nov; 21(11):3052-4. PubMed ID: 16870672
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations of serum and placental endoglin in pre-eclampsia.
    Fang M; He Y; Li H; Wu M; Shi X; Du H
    J Int Med Res; 2010; 38(1):43-51. PubMed ID: 20233512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.
    Salahuddin S; Lee Y; Vadnais M; Sachs BP; Karumanchi SA; Lim KH
    Am J Obstet Gynecol; 2007 Jul; 197(1):28.e1-6. PubMed ID: 17618745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble endoglin contributes to the pathogenesis of preeclampsia.
    Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
    Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis.
    Shan HY; Rana S; Epstein FH; Stillman IE; Karumanchi SA; Williams ME
    Am J Kidney Dis; 2008 Jun; 51(6):1029-32. PubMed ID: 18455853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric nephrology: preeclampsia--the nephrologist's perspective.
    Umans JG
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2107-13. PubMed ID: 23065496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis.
    de Jesus GR; de Jesus NR; Levy RA; Klumb EM
    Lupus; 2014 Oct; 23(12):1299-301. PubMed ID: 25228732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
    Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
    Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies.
    Toft JH; Lian IA; Tarca AL; Erez O; Espinoza J; Eide IP; Bjørge L; Draghici S; Romero R; Austgulen R
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):267-73. PubMed ID: 18330824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of antiangiogenic factors in the placental structures in pre-eclampsia.
    Shchyogolev AI; Dubova EA; Pavlova KA; Lyapin VM; Sukhikh GT
    Bull Exp Biol Med; 2012 Dec; 154(2):287-91. PubMed ID: 23330145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.
    Staff AC; Braekke K; Johnsen GM; Karumanchi SA; Harsem NK
    Am J Obstet Gynecol; 2007 Aug; 197(2):176.e1-6. PubMed ID: 17689641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.
    Masoura S; Kalogiannidis IA; Gitas G; Goutsioulis A; Koiou E; Athanasiadis A; Vavatsi N
    J Obstet Gynaecol; 2012 Oct; 32(7):609-16. PubMed ID: 22943702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.